Adaptive Biotechnologies's market cap is currently $1.22B. The company's EPS TTM is $-1.085; its P/E ratio is ―; Adaptive Biotechnologies is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 170.28M	$ 185.31M	$ 154.34M	$ 98.38M	$ 85.07M
Gross Profit	$ 94.72M	$ 127.40M	$ 105.04M	$ 75.85M	$ 62.80M
Operating Income	$ -227.03M	$ -200.19M	$ -208.97M	$ -152.82M	$ -78.39M
EBITDA	$ -189.27M	$ -167.98M	$ -193.34M	$ -144.34M	$ -70.60M
Net Income	$ -225.25M	$ -142.46M	$ -205.61M	$ -139.64M	$ -58.82M
Balance Sheet
Cash & Short-Term Investments	$ 346.40M	$ 498.20M	$ 353.06M	$ 688.27M	$ 576.87M
Total Assets	$ 661.13M	$ 856.62M	$ 923.34M	$ 1.12B	$ 912.30M
Total Debt	$ 229.43M	$ 108.00M	$ 111.74M	$ 107.86M	$ 36.61M
Net Debt	$ 164.37M	$ 17.97M	$ -27.32M	$ -15.57M	$ -59.97M
Total Liabilities	$ 352.86M	$ 392.52M	$ 319.24M	$ 373.15M	$ 341.26M
Stockholders' Equity	$ 308.40M	$ 464.17M	$ 603.99M	$ 743.27M	$ 571.04M
Cash Flow
Free Cash Flow	$ -167.02M	$ -200.29M	$ -254.47M	$ -168.49M	$ 194.20M
Operating Cash Flow	$ -156.32M	$ -183.94M	$ -192.73M	$ -149.68M	$ 205.40M
Investing Cash Flow	$ 129.65M	$ 2.90M	$ 181.21M	$ -117.04M	$ -481.70M
Financing Cash Flow	$ 2.25M	$ 132.26M	$ 27.15M	$ 293.59M	$ 319.92M

Currency in USD

Adaptive Biotechnologies Earnings and Revenue History

Income Statement >

Adaptive Biotechnologies Debt to Assets

Balance Sheet >

Adaptive Biotechnologies Cash Flow

Cash Flow >

Adaptive Biotechnologies Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing